Invasive aspergillosis complication in yellow fever vaccine induced viscerotropic disease

Invasive aspergillosis (IA) usually occurs in immunocompromised hosts, but in the last decade IA has emerged in critically ill non-neutropenic patients, as those with severe Influenza and Chronic Obstructive Pulmonary Disease (COPD). We report an unusual fatal case of disseminated IA in a non-immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Breda, Giovanni Luis, Domino, Natália Ramos, de Noronha, Lucia, Duarte dos Santos, Claudia N., Zanluca, Camila, Kruger, Rodrigo Sfredo, Queiroz-Telles, Flávio, Raboni, Sonia Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522283/
https://www.ncbi.nlm.nih.gov/pubmed/33014700
http://dx.doi.org/10.1016/j.mmcr.2020.09.002
Descripción
Sumario:Invasive aspergillosis (IA) usually occurs in immunocompromised hosts, but in the last decade IA has emerged in critically ill non-neutropenic patients, as those with severe Influenza and Chronic Obstructive Pulmonary Disease (COPD). We report an unusual fatal case of disseminated IA in a non-immunocompromised patient following yellow fever vaccine-associated viscerotropic disease.

Ejemplares similares